Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy
Christopher A. Klebanoff, … , Richard M. Siegel, Nicholas P. Restifo
Christopher A. Klebanoff, … , Richard M. Siegel, Nicholas P. Restifo
Published December 14, 2015
Citation Information: J Clin Invest. 2016;126(1):318-334. https://doi.org/10.1172/JCI81217.
View: Text | PDF
Research Article Immunology Oncology Article has an altmetric score of 28

Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy

  • Text
  • PDF
Abstract

Adoptive cell transfer (ACT) of purified naive, stem cell memory, and central memory T cell subsets results in superior persistence and antitumor immunity compared with ACT of populations containing more-differentiated effector memory and effector T cells. Despite a clear advantage of the less-differentiated populations, the majority of ACT trials utilize unfractionated T cell subsets. Here, we have challenged the notion that the mere presence of less-differentiated T cells in starting populations used to generate therapeutic T cells is sufficient to convey their desirable attributes. Using both mouse and human cells, we identified a T cell–T cell interaction whereby antigen-experienced subsets directly promote the phenotypic, functional, and metabolic differentiation of naive T cells. This process led to the loss of less-differentiated T cell subsets and resulted in impaired cellular persistence and tumor regression in mouse models following ACT. The T memory–induced conversion of naive T cells was mediated by a nonapoptotic Fas signal, resulting in Akt-driven cellular differentiation. Thus, induction of Fas signaling enhanced T cell differentiation and impaired antitumor immunity, while Fas signaling blockade preserved the antitumor efficacy of naive cells within mixed populations. These findings reveal that T cell subsets can synchronize their differentiation state in a process similar to quorum sensing in unicellular organisms and suggest that disruption of this quorum-like behavior among T cells has potential to enhance T cell–based immunotherapies.

Authors

Christopher A. Klebanoff, Christopher D. Scott, Anthony J. Leonardi, Tori N. Yamamoto, Anthony C. Cruz, Claudia Ouyang, Madhu Ramaswamy, Rahul Roychoudhuri, Yun Ji, Robert L. Eil, Madhusudhanan Sukumar, Joseph G. Crompton, Douglas C. Palmer, Zachary A. Borman, David Clever, Stacy K. Thomas, Shashankkumar Patel, Zhiya Yu, Pawel Muranski, Hui Liu, Ena Wang, Francesco M. Marincola, Alena Gros, Luca Gattinoni, Steven A. Rosenberg, Richard M. Siegel, Nicholas P. Restifo

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2009 Total
Citations: 6 13 11 20 20 21 13 21 19 11 1 1 157
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2020 (21)

Title and authors Publication Year
Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K. Lundgren, Xuming Mao, Silvio Manfredo-Vieira, Selene Nunez-Cruz, Erik F. Williams, Charles-Antoine Assenmacher, Enrico Radaelli, Sangwook Oh, Baomei Wang, Christoph T. Ellebrecht, Joseph A. Fraietta, Michael C. Miloneǂ, Aimee S. Payne
Journal of Clinical Investigation 2020
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells
CM Mousset, W Hobo, A de Ligt, S Baardman, NP Schaap, JH Jansen, AB van der Waart, H Dolstra
Cancer Immunology, Immunotherapy 2020
Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HBV Replication through Production of IFN-γ and TNF-⍺
M Haque, F Lei, X Xiong, Y Ren, A Kumar, JK Das, X Ren, D Fang, P de Figueiredo, JM Yang, J Song
iScience 2020
Group O plasma as a media supplement for CAR‐T cells and other adoptive T‐cell therapies
RC Nelson, V Fellowes, P Jin, H Liu, SL Highfill, J Ren, J Szymanski, WA Flegel, DF Stroncek
Transfusion 2020
Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
E Chruściel, Z Urban-Wójciuk, Ł Arcimowicz, M Kurkowiak, J Kowalski, M Gliwiński, T Marjański, W Rzyman, W Biernat, R Dziadziuszko, C Montesano, R Bernardini, N Marek-Trzonkowska
Cancers 2020
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
LD Galva, L Cai, Y Shao, Y He
Journal of genetics and genomics = Yi chuan xue bao 2020
Development of CAR-T cell therapy for B-ALL using a point-of-care approach
L de Macedo Abdo, LR Barros, MS Viegas, LV Marques, P de Sousa Ferreira, L Chicaybam, MH Bonamino
OncoImmunology 2020
Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer
E Lafont
Cancers 2020
Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
A Gavriil, M Barisa, E Halliwell, J Anderson
Cancers 2020
Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death
SS Ghare, PM Chilton, AV Rao, S Joshi-Barve, P Peyrani, AR Vega, CJ McClain, K Bryant, RL Cook, M Freiberg, S Barve
Journal of acquired immune deficiency syndromes (1999) 2020
Memory T cells: strategies for optimizing tumor immunotherapy
Q Liu, Z Sun, L Chen
Protein & Cell 2020
Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
T Mika, S Ladigan-Badura, A Maghnouj, B Mustafa, S Klein-Scory, A Baraniskin, S Döhring, I Fuchs, S Ehl, SA Hahn, R Schroers
Frontiers in Oncology 2020
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 + T cells
CJ Dwyer, DC Arhontoulis, GO Rivera, HM Knochelmann, AS Smith, MM Wyatt, MP Rubinstein, C Atkinson, JE Thaxton, DM Neskey, CM Paulos
European Journal of Immunology 2020
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
SJ Im, SJ Ha
Immune Network 2020
Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy
M Feist, Z Zhu, E Dai, C Ma, Z Liu, E Giehl, R Ravindranathan, SJ Kowalsky, N Obermajer, US Kammula, AJ Lee, MT Lotze, ZS Guo, DL Bartlett
Cancer Gene Therapy 2020
Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19
AJ Leonardi, RB Proenca
Frontiers in immunology 2020
Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
S Arcangeli, L Falcone, B Camisa, FD Girardi, M Biondi, F Giglio, F Ciceri, C Bonini, A Bondanza, M Casucci
Frontiers in immunology 2020
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
ME Maccari, S Fuchs, P Kury, G Andrieux, S Völkl, B Bengsch, MR Lorenz, M Heeg, J Rohr, S Jägle, CN Castro, M Groß, U Warthorst, C König, I Fuchs, C Speckmann, J Thalhammer, FG Kapp, MG Seidel, G Dückers, S Schönberger, C Schütz, M Führer, R Kobbe, D Holzinger, C Klemann, P Smisek, S Owens, G Horneff, R Kolb, N Naumann-Bartsch, M Miano, J Staniek, M Rizzi, T Kalina, P Schneider, A Erxleben, R Backofen, A Ekici, CM Niemeyer, K Warnatz, B Grimbacher, H Eibel, A Mackensen, AP Frei, K Schwarz, M Boerries, S Ehl, A Rensing-Ehl
Journal of Experimental Medicine 2020
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
M Kroemer, C Turco, L Spehner, J Viot, I Idirène, A Bouard, E Renaude, M Deschamps, Y Godet, O Adotévi, S Limat, B Heyd, M Jary, R Loyon, C Borg
Journal for ImmunoTherapy of Cancer 2020
Modes of Communication between T Cells and Relevance for Immune Responses
L Uhl, A Gérard
International journal of molecular sciences 2020
Additional possibilities of chimeric antigen receptor T-cells in B-cell lymphoma: combination therapy
Y Yang, J Zhou, C Cao, P Cai, X Wang, C Chang, J Wang, Q Zhang
Translational cancer research 2020

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 33 X users
Referenced in 19 patents
On 2 Facebook pages
Mentioned in 1 Google+ posts
337 readers on Mendeley
See more details